From: Metformin versus levonorgestrel-releasing intrauterine system in the management of endometrial hyperplasia: a randomized clinical trial
Variables
Δ ET in mirena
Δ ET in Metformin
r
p-value
R
Age
0.358
0.094a
0.425
0.043a
Menopausal years
0.015
0.95a
-0.029
0.933a
Parity
-0.486
0.019a
0.278
0.199a
BMI (kg/m2)
-0.064
0.773a
0.581
0.004a